HSBC Holdings’s Genomic Health, Inc. GHDX Stock Holding History

HSBC Holdings’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,164	Closed	-$215K	–	3284
2019 Q3	$215K	Sell	3,164 -10,844	-77%	-$745K	﹤0.01%	2830
2019 Q2	$815K	Sell	14,008 -24,186	-63%	-$1.43M	﹤0.01%	1864
2019 Q1	$2.68M	Buy	38,194 +25,772	+207%	+$1.91M	﹤0.01%	1376
2018 Q4	$797K	Buy	+12,422	New	+$871K	﹤0.01%	1908

HSBC Holdings's GHDX Position: Q4 2019 in Review

HSBC Holdings sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 3,164 shares — an estimated $215K sold.

HSBC Holdings first reported a position in GHDX in Q4 2018 and held it in 4 quarters. The position peaked at $2.68M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

HSBC Holdings reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
HSBC Holdings sold 3,164 Genomic Health, Inc. shares in Q4 2019, an estimated $215K.
HSBC Holdings first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 4 quarters.
HSBC Holdings's Genomic Health, Inc. position peaked at $2.68M in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on HSBC Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.